İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2017 · article

Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

YÖKSİS OpenAlex Açık erişim · bronze Üst %10
Yıl2017
Atıf55OpenAlex
Yüzdelik%90,6
FWCI2,541,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıAntimicrobial Agents and Chemotherapy
  • Katalog eşleşmesi (ISSN)Antimicrobial Agents and Chemotherapy
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

β-Lactam/β-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum-β-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and the definitive therapy cohort (251 patients). The 30-day case fatality rates and other secondary outcomes were similar in the two therapy groups of the two cohorts and also in the propensity-matched cohorts. BLBLIs might be carbapenem-sparing alternatives for the treatment of BSI due to ESBLs in these patients.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

55atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 4 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2022 European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM \u2013European Society of intensive care Medicine)Atıf 1.079 · OpenAlex
  2. 2019 Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing optionsAtıf 27 · OpenAlex
  3. 2021 Efficacy of β-lactam/β-lactamase inhibitors to treat extendedspectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)Atıf 25 · OpenAlex
  4. 2021 Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).Atıf 25 · OpenAlex

Yazarlar

24
  1. Carlota Gudiol 1
  2. Cristina Royo-Cebrecos 2
  3. Edson Abdala 3
  4. MURAT AKOVA HACETTEPE ÜNİVERSİTESİ 4
  5. Rocío Álvarez 5
  6. de la Calle Maestro 6
  7. Angela Cano 7
  8. Carlos Cervera 8
  9. Wanessa T Clemente 9
  10. Pilar Martín-Dávila 10
  11. Alison Freifeld 11
  12. Lucía Gómez 12
  13. Thomas Gottlieb 13
  14. Mercè Gurguí 14
  15. Fabián Herrera 15
  16. Adriana Manzur 16
  17. Georg Maschmeyer 17
  18. Miguel Montejo 18
  19. Maddalena Peghin 19
  20. Jesús Rodríguez-Baño 20
  21. Isabel Ruiz-Camps 21
  22. Teresa C Sukiennik 22
  23. Cristian Tebe 23
  24. Jordi Carratalà 24